EUVIMEDEUVIMED entdecken
Crossref

PAG1 aggravates diabetic nephropathy through TGF-β1/Smads-driven pyroptosis

Xue Han, Chen Xie, Song Xue

General physiology and biophysics · 2026 · 45 (03) · 245-257

DOI: 10.4149/gpb_2026006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift General physiology and biophysics, 2026. Verfasst von Xue Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Endocrinology, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Transforming Growth Factor beta1, Pyroptosis, Smad Proteins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) has been recognized as a biomarker for diabetic nephropathy (DN). This study aimed to elucidate the mechanism by which PAG1 influences DN. The expression and clinical significance of PAG1 in DN were assessed using bioinformatics analysis. PAG1 expression was validated in db/db mice and high glucose (HG)-treated human kidney-2 (HK-2) cells. Subsequently, PAG1 was knocked down in DN models to investigate its effects on DN progression, pyroptosis, and the transforming growth factorbeta 1 (TGF-β1)/Smads pathway. The TGF-β1/Smads pathway activator SRI-011381 was employed to further elucidate the role of PAG1 in DN regulation. Bioinformatics analysis revealed elevated PAG1 expression in DN samples, which correlated with various immune cells and pathways, such as chemokine pathway and cell cycle. This elevated expression was confirmed in animal and cell experiments. In db/db mice, PAG1 knockdown alleviated DN, reduced inflammatory factor levels, inhibited pyroptosis, and suppressed TGF-β1/Smads pathway. In vitro, PAG1 silencing promoted proliferation, inhibited apoptosis and fibrosis, reduced inflammatory and pyroptotic factor levels, and suppressed the TGF-β1/Smads pathway. These effects were reversed by SRI-011381 intervention. PAG1 promotes pyroptosis by upregulating the TGF-β1/Smads pathway, thereby exacerbating DN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesTransforming Growth Factor beta1PyroptosisSmad ProteinsMembrane ProteinsAdaptor Proteins, Signal TransducingAnimalsMiceHumansMaleSignal TransductionMice, Inbred C57BLCell Line

Substanzen

Transforming Growth Factor beta1Smad ProteinsMembrane ProteinsAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Nephrology and Endocrinology, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China.

Zitieren

APA

Han, X., Xie, C., & Xue, S. (2026). PAG1 aggravates diabetic nephropathy through TGF-β1/Smads-driven pyroptosis. General physiology and biophysics, 45(03), 245-257. https://doi.org/10.4149/gpb_2026006

Vancouver

Han X, Xie C, Xue S. PAG1 aggravates diabetic nephropathy through TGF-β1/Smads-driven pyroptosis. General physiology and biophysics. 2026;45(03):245-257. doi:10.4149/gpb_2026006

BibTeX
@article{Han2026,
  author = {Han, Xue and Xie, Chen and Xue, Song},
  title = {PAG1 aggravates diabetic nephropathy through TGF-β1/Smads-driven pyroptosis},
  journal = {General physiology and biophysics},
  year = {2026},
  volume = {45},
  number = {03},
  pages = {245--257},
  doi = {10.4149/gpb_2026006}
}
Kostenlos starten →